- Mycophenolate Mofetil Overdose Induced Ventricular Tachycardia in a Patient with Systemic Lupus Erythematosus
-
Kim JH, Chung H, Lee KA, Kim HR, Lee SH
- KMID: 2462832
- Korean J Med.
- 2019 Oct;94(5):455-458.
- doi: 10.3904/kjm.2019.94.5.455
Mycophenolate mofetil (MMF) is an immunosuppressive agent used to treat severe lupus, including lupus nephritis. Common adverse effects of MMF include gastrointestinal and hematological manifestations; however, cardiac toxicity in association... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Hypogammaglobulinemia Associated with Active Lupus Nephritis Treatment Resulting in Cytomegalovirus Infection
-
Chung MK, Kang Y, Lee J
- KMID: 2459452
- J Rheum Dis.
- 2019 Oct;26(4):273-277.
- doi: 10.4078/jrd.2019.26.4.273
Patients with severe active lupus nephritis (LN) require immunosuppressive therapy to induce remission. However, the development of profound hypogammaglobulinemia causing cytomegalovirus (CMV) disease is a rare occurrence during standard immunotherapy.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry
-
Jung UH, Kwak SG, Choe JY, Lee SS, Kim SK
- KMID: 2451548
- J Korean Med Sci.
- 2019 Jul;34(27):e185.
- doi: 10.3346/jkms.2019.34.e185
BACKGROUND: The objective of this study was to identify the effects of mycophenolate mofetil (MMF) on non-renal manifestations in systemic lupus erythematosus (SLE). METHODS: The study population comprised 439 SLE patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hepatic Inflammatory Pseudotumor Occurred in a Patient with Lupus Nephritis
-
Kim MJ, Kim H, Song YJ, Cho SK, Sung YK
- KMID: 2442025
- J Rheum Dis.
- 2019 Apr;26(2):137-141.
- doi: 10.4078/jrd.2019.26.2.137
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease affecting various organs. Among its manifestations, inflammatory pseudotumor (IPT) is an extremely rare disease about which no case has been reported... -
- CITED
-
- Close
- SHARE
-
- Close
- Induction Treatment of Lupus Nephritis in Asian Countries: Is There a “Best†Therapy?
-
Lee J
- KMID: 2442018
- J Rheum Dis.
- 2019 Apr;26(2):90-92.
- doi: 10.4078/jrd.2019.26.2.90
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Antepartum Diagnosis and Treatment of Diffuse Alveolar Hemorrhage in a Pregnant Woman with Systemic Lupus Erythematosus
-
Kim HS, Jeon HS, Han SJ, Kim JH, Chang JH, Oh YK, Shin K, Kim BJ, Lee SM
- KMID: 2443174
- Perinatology.
- 2019 Mar;30(1):32-35.
- doi: 10.14734/PN.2019.30.1.32
Diffuse alveolar hemorrhage (DAH) is a rare and life-threatening complication of systemic lupus erythematosus. Differential diagnosis and successful management of DAH can be problematic in pregnancy. We report a case... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Renal Responses to Cyclophosphamide and Mycophenolate Mofetil used as Induction Therapies in Korean Patients with Lupus Nephritis
-
Choi SE, Park DJ, Kang JH, Lee KE, Xu H, Lee JS, Choi YD, Lee SS
- KMID: 2442035
- J Rheum Dis.
- 2019 Jan;26(1):57-65.
- doi: 10.4078/jrd.2019.26.1.57
OBJECTIVE: Although intravenous cyclophosphamide (IVC) is generally accepted as the standard therapy for induction treatment of active proliferative lupus nephritis (LN), several clinical trials have suggested that mycophenolate mofetil (MMF)... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiphospholipid Antibody Positivity and the Clinical Outcomes of Patients with Systemic Lupus Erythematosus
-
Nam SW, Cho SK, Kim D, Lee KE, Park DJ, Lee SS, Sung YK
- KMID: 2429710
- J Rheum Dis.
- 2018 Oct;25(4):239-247.
- doi: 10.4078/jrd.2018.25.4.239
OBJECTIVE: To identify the prevalence of antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE) patients and determine the relationship between aPL and the clinical outcomes. METHODS: SLE patients with aPL test... -
- CITED
-
- Close
- SHARE
-
- Close
- Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry
-
Kim SK, Choe JY, Lee SS
- KMID: 2428912
- Yonsei Med J.
- 2018 Sep;59(7):857-864.
- doi: 10.3349/ymj.2018.59.7.857
PURPOSE: The aim of this study was to identify the associations among physical activity, disease activity, and organ damage in patients with systemic lupus erythematosus (SLE). MATERIALS AND METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Wolves Trapped in the NETs–The Pathogenesis of Lupus Nephritis
-
Kim Y, Shim SC
- KMID: 2408926
- J Rheum Dis.
- 2018 Apr;25(2):81-99.
- doi: 10.4078/jrd.2018.25.2.81
Systemic lupus erythematous (SLE) is a systemic autoimmune disease with multi-organ inflammation caused by the production of pathogenic autoantibodies and immune complexes reflecting a global loss of tolerance. Lupus nephritis... -
- CITED
-
- Close
- SHARE
-
- Close
- New insights into the role of renal resident cells in the pathogenesis of lupus nephritis
-
Kwok SK, Tsokos GC
- KMID: 2411538
- Korean J Intern Med.
- 2018 Mar;33(2):284-289.
- doi: 10.3904/kjim.2017.383
Systemic lupus erythematosus (SLE), an autoimmune disease of unknown etiology, is characterized by the production of autoantibodies and end-organ damage. Lupus nephritis affects up to 70% of patients with SLE... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus
-
Tani C, Vagnani S, Carli L, Querci F, Kühl AA, Spieckermann S, Cieluch CP, Pacini S, Fazzi R, Mosca M
- KMID: 2400870
- Int J Stem Cells.
- 2017 Nov;10(2):160-168.
- doi: 10.15283/ijsc17014
OBJECTIVE: Pre-clinical and uncontrolled studies in patients with systemic lupus erythematosus (SLE) showed that mesenchymal stromal cells (MSCs) have a potential therapeutic role in refractory cases. The optimal therapeutic strategy... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Mean Platelet Volume with Systemic Lupus Erythematosus Disease Activity: A Meta-analysis
-
Lee YH, Song GG
- KMID: 2394343
- J Rheum Dis.
- 2017 Oct;24(5):279-286.
- doi: 10.4078/jrd.2017.24.5.279
OBJECTIVE: A series of common blood tests neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and mean platelet volume (MPV) could provide a measure of systemic lupus erythematosus... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus
-
Jhou JP, Chen SJ, Huang HY, Lin WW, Huang DY, Tzeng SJ
- KMID: 2394312
- Exp Mol Med.
- 2017 Sep;49(9):e381.
- doi: 10.1038/emm.2017.144
Resveratrol, an anti-inflammatory agent, can inhibit pro-inflammatory mediators by activating Sirt1, which is a class III histone deacetylase. However, whether resveratrol can regulate inhibitory or anti-inflammatory molecules has been less... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics of hypertensive encephalopathy in pediatric patients
-
Ahn CH, Han SA, Kong YH, Kim SJ
- KMID: 2390505
- Korean J Pediatr.
- 2017 Aug;60(8):266-271.
- doi: 10.3345/kjp.2017.60.8.266
PURPOSE: The aim of this study was to assess the clinical characteristics of hypertensive encephalopathy according to the underlying etiologies in children. METHODS: We retrospectively evaluated 33 pediatric patients who were... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis a Biomarker of Lupus Nephritis?
-
Min JK
- KMID: 2385337
- J Rheum Dis.
- 2017 Jun;24(3):125-126.
- doi: 10.4078/jrd.2017.24.3.125
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
-
Hirai K, Ookawara S, Kitano T, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Mori H, Yoshida I, Kubota K, Yamaji Y, Takeda T, Nakamura Y, Tabei K, Morishita
- KMID: 2384618
- Kidney Res Clin Pract.
- 2017 Jun;36(2):159-166.
- doi: 10.23876/j.krcp.2017.36.2.159
BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis as a Biomarker for Lupus Nephritis: A Meta-analysis
-
Lee YH, Song GG
- KMID: 2378086
- J Rheum Dis.
- 2017 Apr;24(2):85-92.
- doi: 10.4078/jrd.2017.24.2.85
OBJECTIVE: This study evaluates serum or urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) as a biomarker for lupus nephritis (LN). METHODS: We conducted a meta-analysis examining serum or urinary... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-bullous Neutrophilic Dermatosis in a Patient with Lupus Nephritis
-
Lee HJ, Kim JM, Kim GW, Moon JH, Kim HS, Ko HC, Kim BS, Kim MB, Song M
- KMID: 2368894
- Korean J Dermatol.
- 2016 Dec;54(10):807-810.
Neutrophilic infiltrates of skin in the setting of lupus patients with bullous systemic lupus erythematosus (SLE) and leukocytoclastic vasculitis are well documented. However, most dermatology studies do not consider cutaneous... -
- CITED
-
- Close
- SHARE
-
- Close
- Autoimmune Hepatitis-systemic Lupus Erythematosus Overlap Syndrome Diagnosed after Tapering Immunosuppressive Therapy
-
Lee BH, Park SA, Kim JK, Cheon DY, Kang SH, Choi NY, Park JW, Kwon MJ, Seo YI, Kim SE
- KMID: 2307747
- Keimyung Med J.
- 2016 Jun;35(1):44-49.
- doi: 10.0000/kmj.2016.35.1.44
The differential diagnosis of systemic lupus erythematosus (SLE) and autoimmune hepatitis (AIH) is difficult due to the resemblance of these two disorders. However, the accurate diagnosis is important for prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
